Group items tagged

Founded in 1966 in Portland, Oregon, the National Psoriasis Foundation works to advance research efforts aimed at curing psoriatic disease and improving the lives of the more than eight million Americans living with psoriasis and psoriatic arthritis. In support if that mission, the foundation is accepting proposals for its 2019 Bridge Grants, which support researchers who have submitted an exemplary but unfunded K-type (career development) or R-type application to the National Institutes of Health or similar funding body, with a focus on psoriatic disease or related co-morbidities. Funding will provide a critical year of additional support to near-miss applicants so that they have the opportunity to continue to collect data that will strengthen a future application.

The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

The Foundation for Physical Therapy Research is dedicated to improving the quality and delivery of patient care by providing support to emerging investigators working to promote scientifically based and clinically relevant research related to the effectiveness of physical therapist practice. To that end, the foundation is accepting applications for its Goergeny High Impact/High Priority Research Grant. Through the program, a grant of up to $360,000 over three years ($240,000 over two years, with the possibility of a competitive third-year renewal) will be awarded to a physical therapist investigator focused on the role of physical therapy in the prevention of secondary health conditions, impairments of body structures and functions, activity limitations, and/or participation restrictions.

CDC announces the availability of Fiscal Year (FY) 2018 funds to implement CDC-RFA-DP18-1809: High Obesity Program. The growing body of evidence suggests that obesity is one of the most significant challenges facing the public health system. If this continues, obesity and the many complications it causes will increase the disease burden in the United States. Poor nutrition and low levels of physical activity affect overall health and are significant risk factors for obesity and other chronic diseases. Obesity in the United States affects 78.6 million (35%) adults and 12.7 million (17%) children and accounts for approximately $147 billion in annual health care costs. The burden of obesity and other chronic diseases negatively affects our nation's businesses, economy, and military readiness and is higher among certain racial/ethnic populations and geographical locations. This five-year program provides resources for land grant universities to leverage community extension services to implement evidence-based strategies that increase access to places that provide healthier foods and safe and accessible places for physical activity in counties with an adult obesity rate of over 40%.

The purpose of the Section Health Policy and Administration Grant Program is to stimulate, encourage and support research activities that enhance the body of knowledge related to health policy, clinical administration, global health, and the use of technology in physical therapy. The grants provide funding to assist new physical therapist investigators, or established investigators who are embarking on a new research agenda in these areas of physical therapist practice, leadership, administration, or education. Through this grant program, the Section hopes to encourage the development of proposals that will seek financial support from external agencies.

The purpose of this Research Opportunity Announcement (ROA) is to establish the HuBMAP Integration, Visualization and Engagement (HIVE) Collaboratory that will 1) manage the data generated by the Consortium, 2) coordinate internal and external Consortium activities, 3) develop novel tools for visualizing, searching and modelling data and 4) build an atlas of tissue maps. The HIVE will be composed of four Components all of which are expected to work closely together to act as the unified backbone for HuBMAP. The HIVE is expected to work closely with the other funded projects as part of the HuBMAP Consortium to catalyze development of a framework for mapping the human body with high spatial resolution. An application may propose only one Component. However, a coordinated set of separate applications, each describing a separate Component but with a common vision, can be proposed.

The purpose of this Funding Opportunity Announcement (FOA) is to establish the HuBMAP Integration, Visualization & Engagement (HIVE) Collaboratory that will: 1) manage the data generated by the HuBMAP Consortium, 2) coordinate internal and external Consortium activities, 3) develop novel tools for visualizing, searching and modelling data and 4) build an atlas of tissue maps The HIVE will be composed of four Components all of which are expected to work closely together to act as the unified backbone for the HuBMAP. The HIVE is expected to work closely with the other funded projects as part of the HuBMAP Consortium to catalyze development of a framework for mapping the human body with high spatial resolution. An application may propose only one Component. However, a coordinated set of separate applications, each describing a separate Component but with a common vision can be proposed.

The Administration on Aging (AoA), a division of the Administration for Community Living, working with a national network of state, tribal, and local agencies, is committed to ensuring that current and future older adults have the information, tools, and services they need to remain healthy and the support they need to remain independent and active for as long as possible. Recently much has been learned about the individual and societal impact of social isolation and loneliness. Based on current estimates, isolation is a social problem that impacts as many as 17% of older Americans.[i] A large body of literature indicates that social isolation and loneliness have negative impacts on health of older adults and is associated with an increased risk of dying. According to a report by the AARP Public Policy Institute and Stanford University, social isolation among people with Medicare is associated with an estimated $6.7 billion in additional Medicare spending every year.[ii] That's comparable to additional program spending for people with chronic conditions like high blood pressure. Research has linked social isolation and loneliness to higher risks for a variety of physical and mental conditions[iii]. In fact, a Brigham Young University study found that prolonged social isolation is as harmful to health as smoking 15 cigarettes a day, and is more harmful than obesity.[iv]

The program was established in 2005 to fund pain research projects of doctoral-prepared investigators who have not yet attained NIH RO1-level funding. The purpose of the program is to encourage research in pain that adds to the existing body of knowledge and to allow investigators to develop pilot data that will aid them in securing additional major grant funding for continued research.

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest. Specifically, the FOA aims to stimulate research that will: 1) develop and test metrics for evaluating the impact of survivorship care planning; 2) evaluate the impact of survivorship care planning on cancer survivors' morbidity, self-management and adherence to care recommendations, utilization of follow-up care; 3) evaluate effects of planning on systems outcomes, such as associated costs and impact on providers and organizations implementing the care planning; and 4) identify models and processes of care that promote effective survivorship care planning. The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions that improve follow-up care for cancer survivors.

The MBRP Clinical Trial Award mechanism is being offered for the first time in FY17.The objective of this Program Announcement is to explore innovative approaches to accelerate the translation of knowledge advances into new treatments for the Service members who sustain burn injuries. The results of the research funded through the FY17/18 MBRP Clinical Trial Award are expected to increase the body of knowledge and materiel products available to professionals and practitioners in health, medical science, and related fields. The research impact is expected to benefit both civilian and military communities.The FY17/18 MBRP Clinical Trial Award supports clinical research studies with the potential to have a major impact on the prevention, treatment, and mitigation of debilitating burn scars that are relevant to military personnel. The specific intent is to improve functional outcomes and/or assess clinical efficacy and safety of different treatment modalities (e.g., dressing topics, biologics, cell-based therapies, mechanical, photonics).

A rich body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity.  These findings suggest that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This funding opportunity supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. Also listed under R01.

This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase Ill and beyond) application submitted under PAR-18-117 (https://grants.nih.gov/grants/guide/pa-files/PAR-18- 117.html}. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this FOA applies must be relevant to the research mission of the NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of the NCCIH, applicants are encouraged to consult the NCCIH website: (http://www.nccih.nih.gov (http://www.nccih.nih.gov)).